start portlet menu bar

Visualizador de conteúdo da Web

Display portlet menu
end portlet menu bar

Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Mannheimia haemolytica in young calves

Página inicial Conhecimento Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Mannheimia haemolytica in young calves

Efficacy of HIPRABOVIS® SOMNI/Lkt in front of a challenge infection with Mannheimia haemolytica in young calves


The aim of this study was to demonstrate the protection conferred in calves by HIPRABOVIS® SOMNI/Lkt through challenge infection with Mannheimia haemolytica, the most virulent and commonly isolated bacterial pathogen in BRD causing severe fibrinonecrotizing pleuropneumonia in lungs (Griffin D. 2010).

Acerca deste artigo

Autores

Foix, A.; Relancio B., Casademunt, S.; March, R.

Sumário

HIPRABOVIS® SOMNI/Lkt proved to be effective in front of an experimental infection with M. haemolytica presenting significantly fewer respiratory problems and reducing percentage and severity of pneumonic lesions. Therefore, the clinical signs and economic impact associated with the pathogenesis of this bacterial agent could be reduced using this vaccine.

Produtos relacionados

Partilhar